These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10470167)

  • 1. NuMA: evaluation of a new biomarker for the detection of low stage colorectal cancer.
    Briggman J; Genduso R; Camara C; Healy B; Shapiro K; Roos R; Merrifield S; Lifter J; Wu YJ; Elder E; Talamonti M
    Anticancer Res; 1999; 19(4A):2411-4. PubMed ID: 10470167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases.
    Hasholzner U; Stieber P; Zimmermann A; Burges A; Hofmann K; Schmitt UM; Schmeller N; Schalhorn A
    Anticancer Res; 1999; 19(4A):2415-20. PubMed ID: 10470168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
    Hasholzner U; Stieber P; Reiter W; Zimmermann A; Hofmann K; Schalhorn A
    Anticancer Res; 1999; 19(4A):2477-80. PubMed ID: 10470177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW; Jiang B; Han CZ; Jing JX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EIA versus RIA in detecting carcinoembryonic antigen level of patients with metastatic colorectal cancer.
    Wang WS; Lin JK; Lin TC; Chiou TJ; Liu JH; Yen CC; Chen WS; Jiang JK; Yang SH; Wang HS; Chen PM
    Hepatogastroenterology; 2004; 51(55):136-41. PubMed ID: 15011849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M
    Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
    Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
    Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standards, options and recommendations for tumor markers in colorectal cancer].
    Eche N; Pichon MF; Quillien V; Gory-Delabaere G; Riedinger JM; Basuyau JP; Daver A; Buecher B; Conroy T; Dieu L; Bidart JM; Deneux L;
    Bull Cancer; 2001 Dec; 88(12):1177-206. PubMed ID: 11792611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of CA-50 in cases with colorectal cancer].
    Nishida O; Ohmori K; Shiroto H; Sawaguchi Y; Satoh N; Nakajima Y; Manabe K; Kondoh Y; Sano F; Uchino J
    Gan No Rinsho; 1989 Apr; 35(5):605-8. PubMed ID: 2654447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
    Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
    Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer.
    Flamini E; Mercatali L; Nanni O; Calistri D; Nunziatini R; Zoli W; Rosetti P; Gardini N; Lattuneddu A; Verdecchia GM; Amadori D
    Clin Cancer Res; 2006 Dec; 12(23):6985-8. PubMed ID: 17145818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.
    Lee H; Rhee H; Kang HJ; Kim HS; Min BS; Kim NK; Kim H
    Am J Clin Pathol; 2008 May; 129(5):772-9. PubMed ID: 18426738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M; Visokai V; Lipska L; Topolcan O
    Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
    Uehara M; Manaka D; Baba S; Oji Y; Hirata K; Shimizu M; Noguchi M
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis.
    Körner H; Söreide K; Stokkeland PJ; Söreide JA
    Ann Surg Oncol; 2007 Feb; 14(2):417-23. PubMed ID: 17103264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.